Graves’ Disease Serum

In Stock Samples

Lot Number Condition Volume Race/Ethnicity Age Gender Country of Collection Medications Vials Price Action
71781 Graves' Disease 1.0 ML Asian/Pacific Islander 38 Male
Methimazole 5mg QD; QVAR 80mcg/2xday; Propranolol 10mg QD
4 $495.00
68848 Graves' Disease 1.0 ML Native American 63 Male 4 $495.00
69291 Graves' Disease 1.0 ML Asian/Pacific Islander 66 Male
No medications
4 $495.00
69460 Graves' Disease 1.0 ML Asian/Pacific Islander 26 Female
methamisol 2.25 mg 5 days a week
6 $495.00
70526 Graves' Disease 1.0 ML Native American 63 Male 6 $495.00
73325 Graves' Disease 1.0 ML Hispanic/Latino 38 Female
levothyroxine 125mcg QD
8 $495.00
69442 Graves' Disease 1.0 ML Caucasian 44 Female United States (US)
Methimazole 10mg daily, other supplements Methimazole, 5mg, QD Iron, 65mg QD Vitamin D3, 5000 U, QD Pro-Air, PID Vitamin B-12, QD Albuterol Inh PRN busparone 10mg QD
6 $495.00
69353 Graves' Disease 1.0 ML African American 60 Female United States (US)
Vitamins, C, E, D, biotin, selenium, velafaxine 150mg and 75mg, Meloxicam, methamazol, metoprolol, atorvastatin, buspar Adorvastin Venlofaxin Metropolol
6 $495.00
68889 Graves' Disease 1.0 ML Other 35 Female United States (US)
methimazole 5-10mg QD
4 $495.00
67076 Graves' Disease 1.0 ML Other 35 Female United States (US)
methimazole 5-10mg QD
2 $495.00

Human Graves’ Disease Serum for Research

Our Graves’ Disease Serum is sourced from IRB-consented donors clinically diagnosed with Graves’ Disease. Each sample is processed and frozen within 24 hours of collection to ensure consistency and high quality for hormone and autoantibody studies.

Product Features

  • Collected from clinically confirmed Graves’ Disease donors
  • Research Use Only (RUO)
  • IRB-approved protocols with documented consent

De-identified Donor Data

  • Diagnosis confirmation
  • Age, sex assigned at birth, and ethnicity
  • Donor-reported allergy and infectious disease history

Applications

  • Biomarker discovery for Graves’ Disease
  • Serum cytokine and protein profiling
  • Therapeutic candidate screening and validation

Compliance and Quality Assurance

  • IRB-approved and HIPAA-compliant protocols
  • Electronic informed consent with 21 CFR Part 11 – compliant e-signatures
  • Documentation support available for regulatory review

Ordering and Customization

Graves’ Disease serum is available in standard and custom volumes. For international orders or documentation requirements, please email learnmore@sanguinebio.com to ensure compatibility with your country’s regulations.

Protocols & Documentation

  • Serum Isolation

    Protocol for serum preparation from whole blood, including collection handling, clarification, and quality documentation.

    Download
  • Informed Consent Form (ICF)

    Available upon request — confirms donor consent for research use and downstream commercialization.

Serum

Frequently Asked Questions

Showing 1–12 of 24 results

Are samples IRB approved?

1 Answer

YES – All collections are conducted under IRB-approved protocols and electronic informed consent. Sanguine utilizes Advarra and WCG IRB for oversight.

YES – with the exception of GMP leukopaks, all our products are research use only (RUO).

Our complete catalog can be found here: https://sanguinebio.com/products/

Storage depends on sample type but often cryopreserved samples stored in liquid nitrogen can be stored for years.

Extensive customization is available. To discuss your project request a quote or email us at learnmore@sanguinebio.com.

Sanguine offers flexible prospective colleciton services to tailored to fit your research. For more information and request a quote, please see: https://sanguinebio.com/prospective-biospecimen-collection-services/

Timelines depend on condition, sample type, and I/E criteria but we often start collection within 2 weeks of signed agreement.

YES – we have in-stock inventory which can be found here https://sanguinebio.com/products/?pro_inventory=inventory. You can also email us at learnmore@sanguinebio.com as we continually get new samples in our inventory.

Each sample from a different individual – Unique donor means each sample comes from a different person, ensuring biological diversity in your study.

YES – Unique donors can be specified and guaranteed based on your requirements.

For information about sample quality, please see: https://sanguinebio.com/quality-and-compliance/

YES – “IRB-approved collection protocols” and IRB approval documentation available upon request. Sanguine utilizes two internationally-recognized IRBs (Advarra and WCG IRB) for review and approval.

1 2
×

Ask a Question

Need a custom Serum cohort?

Our scientific team can scope prospective collections with donor-specific I/E criteria, typically starting within 2 weeks of agreement.

More Information